Cargando…
Plasma protein expression differs between colorectal cancer patients depending on primary tumor location
Colorectal cancer (CRC) includes tumors in the right colon, left colon, and rectum, although they differ significantly from each other in aspects such as prognosis and treatment. Few previous mass spectrometry‐based studies have analyzed differences in protein expression depending on the tumor locat...
Autores principales: | Holm, Matilda, Joenväärä, Sakari, Saraswat, Mayank, Tohmola, Tiialotta, Ristimäki, Ari, Renkonen, Risto, Haglund, Caj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367633/ https://www.ncbi.nlm.nih.gov/pubmed/32452655 http://dx.doi.org/10.1002/cam4.3178 |
Ejemplares similares
-
Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome
por: Holm, Matilda, et al.
Publicado: (2019) -
Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics
por: Holm, Matilda, et al.
Publicado: (2018) -
Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis
por: Saraswat, Mayank, et al.
Publicado: (2017) -
Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis
por: Holm, Matilda, et al.
Publicado: (2022) -
Quantitative glycoproteomics of human milk and association with atopic disease
por: Holm, Matilda, et al.
Publicado: (2022)